Skip to content

Katie Zhou

4 papers in the library · 17 citations · publishing 2022-2026

Papers

Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use.

PNAS nexus April 1, 2025 Katie Zhou, David de Wied, Robin L Carhart-Harris et al. 9 citations

Delusional ideation decreased one month after a planned psychedelic experience, while magical thinking showed no change. Over 30% of participants reported hallucinogen persisting perception disorder (HPPD)-type effects at four weeks, though fewer than 1% found them distressing. Younger age, female gender, a history of psychiatric diagnosis, and baseline trait absorption predicted HPPD-like effects. Lifetime psychedelic use at baseline correlated positively with both magical thinking and delusional ideation, suggesting these traits may correlate with psychedelic use rather than being caused by it.

Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use

November 15, 2022 Katie Zhou, D. de Wied, Robin Carhart‐Harris et al. 8 citations preprint

About a third (32.7%) of people reported symptoms of hallucinogen persisting perception disorder (HPPD) four weeks after a real-world psychedelic experience, but only 2.94% found those symptoms distressing. Delusional ideation was slightly higher among those with more lifetime psychedelic use at baseline, yet it decreased significantly four weeks after the experience, suggesting the baseline correlation may not be causal. Younger age, female gender, a personality trait called absorption, less non-psychedelic substance use in the prior six months, and using psychedelics outside a retreat setting predicted HPPD-like symptoms. The findings are limited by the observational design.

Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach

bioRxiv Preprint Server May 1, 2025 Claudio Agnorelli, Joseph Peill, Gabriela Sawicka et al. preprint

A single psychedelic dose of ketamine (1 mg/kg, intravenous) alters brain chemistry and connectivity in healthy people for at least one to eight days. After the dose, glutamate levels in the anterior cingulate cortex rose significantly. Functional connectivity decreased within high-order networks such as the default mode network, while integration between low- and high-order networks increased. Increases in a PET marker of synaptic plasticity correlated with reduced intrinsic activity in default mode network regions and a diminished influence of the posterior cingulate cortex on global network dynamics. The posterior cingulate cortex appears to be a central hub through which ketamine may reshape brain hierarchies over the long term.

Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism March 21, 2026 Claudio Agnorelli, Joseph Peill, Gabriela Sawicka et al.

A single intravenous dose of ketamine (1 mg/kg) in eleven healthy men altered brain chemistry and connectivity days later. Glutamate levels rose in the anterior cingulate cortex (ACC). Functional coupling between the ACC and the dorsolateral prefrontal cortex decreased, while coupling between the ACC and the amygdala increased. Participants whose PET scans indicated increased synaptic plasticity showed reduced intrinsic activity in default mode network (DMN) regions. The findings suggest the DMN is a central hub where ketamine may reshape brain hierarchies, offering clues to its therapeutic mechanisms.